Lumosa Therapeutics Co., Ltd. (6535.TWO)
TWD 144.0
(-10.0%)
TWD 144.0
(-10.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 227.69 Million TWD | 5.55% |
| 2022 | 215.71 Million TWD | -6.25% |
| 2021 | 230.1 Million TWD | 14.13% |
| 2020 | 201.62 Million TWD | -27.59% |
| 2019 | 278.43 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 203.69 Million TWD | 1.44% |
| 2024 Q1 | 200.8 Million TWD | -11.81% |
| 2023 Q4 | 227.69 Million TWD | 19.32% |
| 2023 Q1 | 192.39 Million TWD | -10.81% |
| 2023 FY | 227.69 Million TWD | 5.55% |
| 2023 Q3 | 190.82 Million TWD | -1.46% |
| 2023 Q2 | 193.66 Million TWD | 0.66% |
| 2022 Q3 | 198.37 Million TWD | 0.0% |
| 2022 Q4 | 215.71 Million TWD | 8.74% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 60.977% |
| Level Biotechnology Inc. | 273.2 Million TWD | 16.657% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -65.206% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | -15.305% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 82.852% |
| GlycoNex Incorporation | 276.39 Million TWD | 17.621% |
| VBI | 21.25 Million TWD | -971.451% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 27.418% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 55.758% |
| Visgeneer Inc. | 185.6 Million TWD | -22.677% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 82.792% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 68.936% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -89.967% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 89.863% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -3340.526% |
| Enimmune corporation | 173.46 Million TWD | -31.264% |
| TaiRx, Inc. | 60.62 Million TWD | -275.578% |
| CHO Pharma, Inc. | 110.83 Million TWD | -105.441% |
| EirGenix Inc. | 1.14 Billion TWD | 80.116% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -103.333% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 55.566% |
| Lin BioScience, Inc. | 167.73 Million TWD | -35.75% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -142.967% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -261.224% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -82.551% |
| Lukas Biomedical Inc. | 161.05 Million TWD | -41.373% |
| RBC Bioscience Corporation | 513.08 Million TWD | 55.622% |
| BiOptic Inc. | 170.56 Million TWD | -33.496% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -440.097% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -879.118% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -749.193% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 76.638% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -3155.562% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -972.713% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 38.182% |
| Neith Corporation | 17.43 Million TWD | -1206.109% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -2756.172% |
| NaviFUS Corp. | 53.4 Million TWD | -326.385% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 52.71% |
| Sinew Pharma Inc. | 39.71 Million TWD | -473.334% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -292.312% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 37.528% |
| AP Biosciences Inc | 106.65 Million TWD | -113.496% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 93.55% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -642.134% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | -16.176% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 85.246% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 73.72% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -2354.657% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -307.959% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 2.26% |
| TCI GENE Inc. | 155.54 Million TWD | -46.382% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -792.638% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -393.111% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 30.68% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -250.909% |
| PharmaEngine, Inc. | 91 Million TWD | -150.197% |
| Savior Lifetec Corporation | 457.95 Million TWD | 50.28% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -105.241% |
| OBI Pharma, Inc. | 650.44 Million TWD | 64.994% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 41.738% |
| Acepodia, Inc. | 384.47 Million TWD | 40.777% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -166.144% |